Medistim ASA (OSL:MEDI)
Norway
· Delayed Price · Currency is NOK 215.00
+5.00 (2.38%)
May 13, 2025, 11:00 AM CET
Medistim ASA Revenue
Medistim ASA had revenue of 181.55M NOK in the quarter ending March 31, 2025, with 35.70% growth. This brings the company's revenue in the last twelve months to 603.92M, up 14.89% year-over-year. In the year 2024, Medistim ASA had annual revenue of 556.16M with 6.73% growth.
Revenue (ttm)
603.92M
Revenue Growth
+14.89%
P/S Ratio
6.35
Revenue / Employee
3.92M
Employees
154
Market Cap
3.83B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 556.16M | 35.05M | 6.73% |
| Dec 31, 2023 | 521.11M | 34.85M | 7.17% |
| Dec 31, 2022 | 486.26M | 68.45M | 16.38% |
| Dec 31, 2021 | 417.82M | 61.61M | 17.30% |
| Dec 31, 2020 | 356.21M | -707.00K | -0.20% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nordhealth AS | 537.23M |
| Photocure ASA | 532.69M |
| Vistin Pharma ASA | 440.66M |
| Nykode Therapeutics AS | 104.04M |
| Hofseth BioCare ASA | 265.54M |
| Omda AS | 426.27M |
| Gentian Diagnostics ASA | 158.07M |
| ArcticZymes Technologies ASA | 102.97M |
Medistim ASA News
- 2 months ago - Medistim ASA (STU:MD1) Q4 2024 Earnings Call Highlights: Record Sales and Strategic Innovations ... - GuruFocus
- 2 months ago - Q4 2024 Medistim ASA Earnings Call Transcript - GuruFocus
- 7 months ago - Medistim ASA (FRA:MD1) Q3 2024 Earnings Call Highlights: Strong Sales Growth in Americas Amid ... - GuruFocus
- 7 months ago - Q3 2024 Medistim ASA Earnings Call Transcript - GuruFocus